The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...
Director-General of Health Patrick Amoth detailed the nationwide distribution plan, with Nairobi receiving the largest ...
The arrival of the first batch of 9.3 million doses of critical childhood jabs is set to alleviate a biting shortage of the ...
Kenyan parents can breathe easy after the country received 9.3 million doses of critical childhood vaccines to address shortages in the country.
Adar Poonawalla, CEO, Serum Institute of India talks to Arijit Barman about concerns of a slowdown in vaccine approvals, on ...
The Star Worldwide (English) on MSN6d
HENNET links vaccine stock-out to reduced budgetHealth Non-Governmental Organisations Network (HENNET) has blamed low budgetary allocation for the recurring vaccine ...
With only seven members, iGEM Eindhoven forms a small but determined student team that aims to help shape the future of ...
DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...
Adar Poonawalla, CEO, Serum Institute of India talks to Arijit Barman about a range of issues including the impact of Trump’s ...
There is consistent evidence that BCG protects against leprosy ... analysis to be carried out to assess the difference of vaccine protection conferred for children vaccinated before 15 years ...
Cyrus Biotechnology Inc. has selected CYR-212, an engineered next-generation reduced-immunogenicity and half-life extended immunoglobulin G (IgG) protease, as a clinical development candidate for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback